https://www.regmednet.com/first-engineered-t-cell-therapy-approved-for-solid-tumors/
FDA approval after the first cohort in the Phase 2 trial.
why is this important?
- T cell therapy is a slight variant to the car T cell therapies being developed by CHM
- therapy was successful against solid tumours
- first ever fda approved t call therapy for solid tumours
https://www.regmednet.com/first-engineered-t-cell-therapy-approve...
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
0.001(6.25%) |
Mkt cap ! $14.63M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.7¢ | 1.6¢ | $3.513K | 212.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 1898286 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 641644 | 5 |
View Market Depth
| Last trade - 15.47pm 27/08/2024 (20 minute delay) ? |
| CHM (ASX) Chart |